ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMM Immupharma Plc

2.385
0.00 (0.00%)
Last Updated: 08:53:06
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.385 2.21 2.39 12,509 08:53:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -2.09 7.93M

Immupharma PLC Annual Financial Report & Notice of AGM (1388X)

04/05/2016 7:01am

UK Regulatory


Immupharma (LSE:IMM)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Immupharma Charts.

TIDMIMM

RNS Number : 1388X

Immupharma PLC

04 May 2016

 
    4 MAY 2016 
 

ANNUAL REPORT AND ACCOUNTS

NOTICE OF ANNUAL GENERAL MEETING: 26 MAY 2016

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2015 has been posted to shareholders.

The Annual Report will be available later today, in electronic form, for download on the Company's website www.immupharma.org.

The Company's Annual General Meeting will be held on Thursday 26 May 2016 at 10:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

 
                                    -Ends- 
 
 
                         For further information please 
                                    contact: 
     ImmuPharma plc (www.immupharma.org)                + 44 (0) 20 7152 4080 
                              Tim McCarthy, Chairman 
                    Lisa Baderoon, Head of Investor Relations 
      Twitter: @immupharma                              + 44 (0) 7721 413496 
 
      Panmure, Gordon (UK) Limited, NOMAD & Broker       +44 (0) 20 7886 2500 
                 Fred Walsh / Duncan Monteith, Corporate Finance 
                    Charles Leigh-Pemberton, Corporate Broking 
 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSSSLFWDFMSELI

(END) Dow Jones Newswires

May 04, 2016 02:01 ET (06:01 GMT)

1 Year Immupharma Chart

1 Year Immupharma Chart

1 Month Immupharma Chart

1 Month Immupharma Chart

Your Recent History

Delayed Upgrade Clock